We are live on ! Find out more
ACM

Accipiter Capital Management Portfolio holdings

AUM $124M
1-Year Est. Return 6.47%
This Fund
S&P 500
This Quarter Est. Return
-19.87%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$48.6M
AUM Growth
+$728K
Cap. Flow
+$11.1M
Cap. Flow %
22.78%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
3
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$9.05M
2
SHPG
Shire pic
SHPG
+$2.03M
3
FELP
Foresight Energy LP
FELP
+$6.02K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Energy 66.32%
2 Healthcare 33.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FELP
1
DELISTED
Foresight Energy LP
FELP
$32.2M 66.32%
7,623,702
+1,400
+0% +$6.02K
TEVA icon
2
Teva Pharmaceuticals
TEVA
$40.4B
$10.6M 21.87%
604,185
+402,040
+199% +$9.05M
SHPG
3
DELISTED
Shire pic
SHPG
$5.74M 11.81%
37,505
+12,927
+53% +$2.03M

Similar funds

ACM
Akanthos Capital Management Woodland Hills, California $122M AUM 17.6% 1-Year Est. Return
MCM
Mobius Capital Management Pleasanton, California $138M AUM 43.22% 1-Year Est. Return
TCM
Triarii Capital Management Boston, Massachusetts $97.9M AUM 0.4% 1-Year Est. Return
ALIONA
Allianz Life Insurance of North America Minneapolis, Minnesota $91.6M AUM 10.06% 1-Year Est. Return
HA
Hays Advisory Franklin, Tennessee $157M AUM 9.67% 1-Year Est. Return
DFIG
Dragon Financial & Investment Group San Mateo, California $88.2M AUM 7.87% 1-Year Est. Return
PAM
Pope Asset Management Memphis, Tennessee $162M AUM
KC
KHP Capital Tulsa, Oklahoma $164M AUM 7.73% 1-Year Est. Return

Accipiter Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Accipiter Capital Management held 3 positions worth $48.6M, up 1.5% from $47.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Accipiter Capital Management deployed $11.1M of net new capital in Q3 2017, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 78% a quarter earlier, followed by Healthcare.

  • Accipiter Capital Management added most to Teva Pharmaceuticals in Q3 2017, an estimated $9.05M increase.
  • Accipiter Capital Management's ten largest holdings make up 100% of its $48.6M portfolio in Q3 2017.
  • Accipiter Capital Management opened 0 new positions and closed 0 in Q3 2017.
  • Accipiter Capital Management's portfolio value rose 1.5% quarter-over-quarter to $48.6M.

Based on Accipiter Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.